Stock Ratings / Health Care / SMMT / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

Summit Therapeutics Inc. Common Stock (SMMT) 12-Month Stock Forecast & Price Target Cone

$16.20 +2.73% NASDAQ • Public Delayed / 60s Snapshot

Summit Therapeutics Inc. Common Stock (SMMT) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.

ROARABLE C • HOLD / WATCH Cap $12.96B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw D · Rk A-

Each axis scored 0–20

12M PRICE TARGET CONE+2.2% Base Target

WHALE OPTIONS TUG-OF-WAR:61% Call Buyers ($2.8M)

39% PutsMax Pain: $16.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your SMMT Position Size: $10,000

Shares at $16.20: 617.3 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $12.92

$7,975

$-2,025 (-20.2%)

12M Consensus BaseTarget $16.56

$10,222

+$222 (+2.2%)

12M Bull Case BreakoutTarget $30.69

$18,944

+$8,944 (+89.4%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (28 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$17	74%	A
Goldman SachsSector Coverage Lead	BUY	$29	69%	B
JP MorganUS Large-Cap Research	HOLD	$15	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live SMMT Tape Review)

✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

SMMT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -25.30%▲ ASCENDING CHANNEL

2026-10-30O $16.03H $16.43L $15.56C $16.03VOL 3.50M

RES: $20.80SUP: $14.56SMA50: $16.06SMA200: $16.18

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

SMMT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 SMMT Butterfly Map → + Track SMMT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

26.2%/yr Implied 5Y Growth

vs. +11.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on SMMT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for SMMT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for SMMT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

SMMT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is SMMT's 12-month stock price target?

Summit Therapeutics Inc. Common Stock (SMMT) carries a 12-month consensus base price target of $16.56 (+2.2% from $16.20), with a bull-case target of $30.69 and a bear-case floor of $12.92.

Is SMMT stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates SMMT C (Hold — HOLD) with an RQD Confidence score of 63/100.

Direct Sub-Reports: SMMT RQD Cockpit SMMT 12M Forecast SMMT Earnings & Move SMMT Dividends & DRIP SMMT Insiders & 13F SMMT Whale Options SMMT Profit Sankey SMMT News & Why